Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04819373
Title BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Birdie Biopharmaceuticals HK Limited
Indications

lung non-small cell carcinoma

renal cell carcinoma

head and neck squamous cell carcinoma

transitional cell carcinoma

skin squamous cell carcinoma

Merkel cell carcinoma

melanoma

Therapies

BDB001

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.